Ryan Case

1.0k total citations
21 papers, 709 citations indexed

About

Ryan Case is a scholar working on Neurology, Molecular Biology and Plant Science. According to data from OpenAlex, Ryan Case has authored 21 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Plant Science. Recurrent topics in Ryan Case's work include Neurological disorders and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Ryan Case is often cited by papers focused on Neurological disorders and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Ryan Case collaborates with scholars based in United States, Austria and Italy. Ryan Case's co-authors include Guido F. Pauli, DD Soejarto, Scott G. Franzblau, Jun Chang, Sang‐Hyun Cho, Taichi Inui, Yuehong Wang, Nikolaus H. Fischer, Yuehong Wang and Arthur O. Tucker and has published in prestigious journals such as Neurology, Journal of Chromatography A and Journal of Ethnopharmacology.

In The Last Decade

Ryan Case

21 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Case United States 14 288 261 114 98 92 21 709
Karin M. Höld United States 17 186 0.6× 283 1.1× 184 1.6× 53 0.5× 29 0.3× 22 940
Hellen Oketch‐Rabah United States 19 425 1.5× 360 1.4× 206 1.8× 108 1.1× 17 0.2× 37 1.1k
M. A. M. Bandeira Brazil 10 309 1.1× 214 0.8× 137 1.2× 103 1.1× 14 0.2× 15 676
Vikram Khetani United States 15 165 0.6× 155 0.6× 45 0.4× 95 1.0× 27 0.3× 25 817
Pei-Lin Wu Taiwan 23 486 1.7× 639 2.4× 138 1.2× 206 2.1× 20 0.2× 33 1.4k
A Laurens France 14 283 1.0× 306 1.2× 68 0.6× 116 1.2× 54 0.6× 41 928
Si-Yuan Shao China 14 238 0.8× 286 1.1× 43 0.4× 49 0.5× 11 0.1× 30 496
Pilar Puebla Spain 17 272 0.9× 497 1.9× 108 0.9× 76 0.8× 10 0.1× 57 1.2k
Vaishali Joshi United States 14 174 0.6× 201 0.8× 63 0.6× 85 0.9× 10 0.1× 29 575
Guilherme Antônio Lopes de Oliveira Brazil 10 265 0.9× 194 0.7× 219 1.9× 118 1.2× 6 0.1× 57 745

Countries citing papers authored by Ryan Case

Since Specialization
Citations

This map shows the geographic impact of Ryan Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Case more than expected).

Fields of papers citing papers by Ryan Case

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Case. The network helps show where Ryan Case may publish in the future.

Co-authorship network of co-authors of Ryan Case

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Case. A scholar is included among the top collaborators of Ryan Case based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Case. Ryan Case is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellenbogen, Aaron, Werner Poewe, Alberto J. Espay, et al.. (2025). Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study. Parkinsonism & Related Disorders. 132. 107293–107293. 2 indexed citations
2.
LeWitt, Peter A., Fabrizio Stocchi, David Arkadir, et al.. (2022). The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program. Frontiers in Neurology. 13. 1036068–1036068. 21 indexed citations
3.
Isaacson, Stuart, Tanya Simuni, Laurence Salin, et al.. (2022). Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Results from the ongoing BeyoND study (P10-11.006). Neurology. 98(18_supplement). 1 indexed citations
4.
Giladi, Nir, Tanya Gurevich, Ruth Djaldetti, et al.. (2021). ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study. Parkinsonism & Related Disorders. 91. 139–145. 34 indexed citations
5.
Case, Ryan, et al.. (2021). Lipids, statins and susceptibility to SARS-CoV-2 and influenza A viruses. Microbiology Australia. 42(2). 87–91. 1 indexed citations
6.
Olanow, C. Warren, Alberto J. Espay, Fabrizio Stocchi, et al.. (2020). Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study. Journal of Parkinson s Disease. 11(1). 177–186. 35 indexed citations
7.
8.
Ellenbogen, Aaron, Fabrizio Stocchi, Alberto J. Espay, et al.. (2020). Impact of Subcutaneous Levodopa Infusion with ND0612 on Patient Reported Outcomes (4506). Neurology. 94(15_supplement). 4 indexed citations
9.
Roumie, Christianne L., Niral Patel, Daniel Muñoz, et al.. (2018). Design and outcomes of the Patient Centered Outcomes Research Institute coronary heart disease cohort study. Contemporary Clinical Trials Communications. 10. 42–49. 5 indexed citations
10.
Pauli, Guido F., Shao‐Nong Chen, David C. Lankin, et al.. (2014). Essential Parameters for Structural Analysis and Dereplication by 1H NMR Spectroscopy. Journal of Natural Products. 77(6). 1473–1487. 73 indexed citations
11.
Case, Ryan, et al.. (2007). Advanced applications of counter-current chromatography in the isolation of anti-tuberculosis constituents from Dracaena angustifolia. Journal of Chromatography A. 1151(1-2). 169–174. 27 indexed citations
12.
Kroll, David J., Nicholas H. Oberlies, Djaja D. Soejarto, et al.. (2007). Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma–associated herpesvirus. Molecular Cancer Therapeutics. 6(8). 2360–2370. 14 indexed citations
13.
Case, Ryan, Scott G. Franzblau, Yuehong Wang, et al.. (2006). Ethnopharmacological evaluation of the informant consensus model on anti-tuberculosis claims among the Manus. Journal of Ethnopharmacology. 106(1). 82–89. 51 indexed citations
14.
Ma, Cuiying, Ryan Case, Yuehong Wang, et al.. (2005). Anti-Tuberculosis Constituents from the Stem Bark ofMicromelum hirsutum. Planta Medica. 71(3). 261–267. 61 indexed citations
15.
Chang, Jun & Ryan Case. (2005). Phenolic glycosides and ionone glycoside from the stem of Sargentodoxa cuneata. Phytochemistry. 66(23). 2752–2758. 47 indexed citations
16.
Pauli, Guido F., Ryan Case, Taichi Inui, et al.. (2005). New perspectives on natural products in TB drug research. Life Sciences. 78(5). 485–494. 139 indexed citations
17.
Chang, Jun & Ryan Case. (2005). Cytotoxic Phenolic Constituents from the Root ofActinidia chinensis. Planta Medica. 71(10). 955–959. 31 indexed citations
18.
Case, Ryan, Guido F. Pauli, & DD Soejarto. (2005). Factors in Maintaining Indigenous Knowledge Among Ethnic Communities of Manus island. Economic Botany. 59(4). 356–365. 111 indexed citations
19.
Inui, Taichi, Ryan Case, Djaja D. Soejarto, et al.. (2005). CCC in the Phytochemical Analysis of Anti‐Tuberculosis Ethnobotanicals. Journal of Liquid Chromatography & Related Technologies. 28(12-13). 2017–2028. 15 indexed citations
20.
Case, Ryan, Arthur O. Tucker, Michael J. Maciarello, & Kraig A. Wheeler. (2003). Chemistry and Ethnobotany of Commercial Incense Copals, Copal Blanco, Copal Oro, and Copal Negro, of North America. Economic Botany. 57(2). 189–202. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin M. Höld Breakdown of academic impact, for papers by Hellen Oketch‐Rabah Breakdown of academic impact, for papers by M. A. M. Bandeira Breakdown of academic impact, for papers by Vikram Khetani Breakdown of academic impact, for papers by Pei-Lin Wu Breakdown of academic impact, for papers by A Laurens Breakdown of academic impact, for papers by Si-Yuan Shao Breakdown of academic impact, for papers by Pilar Puebla Breakdown of academic impact, for papers by Vaishali Joshi Breakdown of academic impact, for papers by Guilherme Antônio Lopes de Oliveira
Rankless by CCL
2026